Kidney Allograft Rejection

• CLINICAL_TRIALS research · 2026-02-17
  Clinical Trial Update: Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA

  A clinical trial is evaluating urinary CXCL10 as a biomarker to improve detection of acute kidney allograft rejection in kidney transplant p…

• CLINICAL_TRIALS withdrawal · 2025-11-20
  Clinical Trial Update: Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation [Phase 1, Phase 2]

  A Phase 1/2 trial evaluating eculizumab for subclinical acute antibody-mediated rejection in kidney transplantation has been withdrawn.

• CLINICAL_TRIALS research · 2025-01-30
  Clinical Trial Update: TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation

  Clinical trial update on TreaT-Assay, a new diagnostic method for acute rejection in kidney transplantation, currently in recruitment. The s…

• CLINICAL_TRIALS trial_result · 2024-12-24
  Clinical Trial Update: Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation. [NA]

  This completed clinical trial from University Hospital, Bordeaux evaluated mass spectrometry-based proteomics for diagnosing microvascular i…

• CLINICAL_TRIALS research · 2024-12-19
  Clinical Trial Update: Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection

  This clinical trial investigates whether circulating donor kidney DNA can serve as a biomarker to detect graft rejection in kidney transplan…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-05-29
  Clinical Trial Update: Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx [Phase 3]

  Phase 3 trial comparing LCP-Tacro (extended-release tacrolimus) to Prograf for prevention of rejection in de novo adult kidney transplant re…